Hannah Kuchler

Hannah Kuchler, The FT's Global Pharmaceutical Editor, dives into the complicated relationship between Big Pharma and the Trump administration. Discussing the proposed 200% tariffs on foreign drugs, she notes surprise market reactions and looming challenges like the looming 'patent cliff.' Kuchler highlights how tariffs could reshape drug pricing and manufacturing in the U.S. She also examines how healthcare policies and regulatory changes impact the pharmaceutical landscape, underscoring the industry's need to adapt in a turbulent environment.

Hannah Kuchler, a Financial Times journalist, dives into the implications of Wegovy, a new weight-loss drug boasting impressive results but raising ethical concerns. She discusses the criticism surrounding its ability to truly address the roots of obesity. Joining her is Lauren Indvik, FT's fashion editor, who shares clever tips for discovering personal style while promoting sustainable fashion choices. From building a versatile wardrobe to mindful consumption, their insights are timely and thought-provoking, challenging the status quo in health and fashion.

Patrick Radden Keefe, an award-winning writer and author of *Empire of Pain*, joins FT’s global pharmaceutical correspondent, Hannah Kuchler. They delve into the Sackler family’s dark legacy tied to the opioid crisis, unraveling their role in promoting OxyContin. Keefe shares insights from his investigative research, exposing corruption and the chilling impact on public health. The discussion spans the ethics of billionaire philanthropy, the Sackler’s influence on art and activism, and the erosion of trust in the healthcare system due to their actions.

Hannah Kuchler, FT's pharmaceutical correspondent, dives deep into the shocking story of Insys Therapeutics, the first drugmaker executives imprisoned for their role in the opioid crisis. She reveals their disturbing bribery schemes aimed at getting doctors to prescribe dangerous fentanyl. The discussion highlights how aggressive marketing overwhelmed ethical practices, contributing directly to widespread addiction. Kuchler also discusses the crucial role of whistleblowers in bringing these legal battles to light and the continuing impact of this scandal on the pharmaceutical industry.

In this episode, the FT's US pharma correspondent, Hannah Kuchler, discusses the fitness inequality in New York City. They explore the booming fitness industry, luxurious fitness studios, and unique workouts. They also highlight the challenges of accessing fitness facilities in certain neighborhoods and the importance of community-based initiatives. The podcast touches on the benefits of exercise, equity in park facilities, and the need for more innovative and inclusive fitness experiences.